Mark Anthony McCamish Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Mark Anthony McCamish.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Mark Anthony McCamish. Mark Anthony McCamish is SVP & CMO in PDL BIOPHARMA, INC. ($PDLI) and Director in AVADEL PHARMACEUTICALS PLC ($AVDL) and President and CEO in Forty Seven, Inc. ($FTSV) and Director in Vincera Pharma, Inc. ($LSAC).

Latest Insider Trading Transactions of Mark Anthony McCamish

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AVDL, FTSV, PDLI, VINCU

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 28 2020LSACVincera Pharma, In ...McCamish Mark AnthonyDirectorOption ExerciseA19.006,667126,6736,667
Sep 18 2020AVDLAVADEL PHARMACEUTI ...McCamish Mark AnthonyDirectorBuyP5.8352,398305,250171,000118.6 K to 171 K (+44.18 %)
Sep 18 2020AVDLAVADEL PHARMACEUTI ...McCamish Mark AnthonyDirectorBuyP5.73118,602679,969118,6020 to 118.6 K
Sep 14 2020AVDLAVADEL PHARMACEUTI ...McCamish Mark AnthonyDirectorOption ExerciseA5.3050,000265,00050,000
Aug 11 2020AVDLAVADEL PHARMACEUTI ...McCamish Mark AnthonyDirectorOption ExerciseA8.4842,000356,16042,000
Apr 07 2020FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseD35.75327,37511,703,6560
Apr 07 2020FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseD8.76184,5161,615,8990
Apr 07 2020FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseD5.27334,2391,761,4400
Apr 07 2020FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseD4.88134,629657,3260
Apr 07 2020FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseD4.88314,3951,535,0340
Apr 07 2020FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOSellD0.004,595004.6 K to 0 (-100.00 %)
Apr 03 2020FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseM4.8827132134,629
Apr 03 2020FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseM4.8830,210147,500314,395
Apr 03 2020FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOSellS95.4230,2372,885,2364,59534.8 K to 4.6 K (-86.81 %)
Apr 03 2020FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOSellS95.412,340223,26834,83237.2 K to 34.8 K (-6.30 %)
Apr 03 2020FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOBuyM4.8830,237147,63237,1726.9 K to 37.2 K (+436.01 %)
Apr 03 2020FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOGiftG0.0060,7190060.7 K to 0 (-100.00 %)
Dec 17 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseA35.75327,37511,703,656327,375
Dec 09 2019AVDLAVADEL PHARMACEUTI ...McCamish Mark AnthonyDirectorOption ExerciseA5.9260,000355,20060,000
Dec 09 2019AVDLAVADEL PHARMACEUTI ...McCamish Mark AnthonyDirectorOption ExerciseA5.9260,000355,20060,000
Jun 27 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseM4.888,19940,032344,605
Jun 27 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOSellS11.028,19990,39160,71968.9 K to 60.7 K (-11.90 %)
Jun 27 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOBuyM4.888,19940,03268,91860.7 K to 68.9 K (+13.50 %)
Jun 24 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseM4.888,30140,530352,804
Jun 24 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOSellS11.048,30191,62660,71969 K to 60.7 K (-12.03 %)
Jun 24 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOBuyM4.888,30140,53069,02060.7 K to 69 K (+13.67 %)
May 22 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseM4.881,2916,303361,105
May 22 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseM4.8815,20974,258362,396
May 22 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOSellS12.461,29116,08060,71962 K to 60.7 K (-2.08 %)
May 22 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOBuyM4.881,2916,30362,01060.7 K to 62 K (+2.13 %)
May 22 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOSellS12.0715,209183,64660,71975.9 K to 60.7 K (-20.03 %)
May 22 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOBuyM4.8815,20974,25875,92860.7 K to 75.9 K (+25.05 %)
Apr 22 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseM4.8816,50080,561377,605
Apr 22 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOSellS18.1216,500299,05460,71977.2 K to 60.7 K (-21.37 %)
Apr 22 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOBuyM4.8816,50080,56177,21960.7 K to 77.2 K (+27.17 %)
Apr 22 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseM4.8816,50080,561377,605
Apr 22 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOSellS18.1216,500299,05460,71977.2 K to 60.7 K (-21.37 %)
Apr 22 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOBuyM4.8816,50080,56177,21960.7 K to 77.2 K (+27.17 %)
Mar 21 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseM4.8816,50080,561394,105
Mar 21 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOSellS18.1516,500299,40160,71977.2 K to 60.7 K (-21.37 %)
Mar 21 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOBuyM4.8816,50080,56177,21960.7 K to 77.2 K (+27.17 %)
Feb 21 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseM4.889,41045,944410,605
Feb 21 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseM4.887,09034,617420,015
Feb 21 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOSellS14.949,410140,54660,71970.1 K to 60.7 K (-13.42 %)
Feb 21 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOBuyM4.889,41045,94470,12960.7 K to 70.1 K (+15.50 %)
Feb 21 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOSellS15.067,090106,79760,71967.8 K to 60.7 K (-10.46 %)
Feb 21 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOBuyM4.887,09034,61767,80960.7 K to 67.8 K (+11.68 %)
Jan 29 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseM4.8820,45499,867134,656
Jan 29 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseM4.8831,233152,495427,105
Jan 29 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOBuyM4.8820,45499,86760,71940.3 K to 60.7 K (+50.80 %)
Jan 29 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOBuyM4.8831,233152,49540,2659 K to 40.3 K (+345.80 %)
Jan 23 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseM4.883,50017,089155,110
Jan 23 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseM4.8816,50080,561458,338
Jan 23 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOSellS14.5920,000291,8929,03229 K to 9 K (-68.89 %)
Jan 23 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOBuyM4.883,50017,08929,03225.5 K to 29 K (+13.71 %)
Jan 23 2019FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOBuyM4.8816,50080,56125,5329 K to 25.5 K (+182.68 %)
Dec 28 2018FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseM4.882,96814,491158,610
Dec 28 2018FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOOption ExerciseM4.889,03244,099474,838
Dec 28 2018FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOSellS15.892,96847,1609,03212 K to 9 K (-24.73 %)
Dec 28 2018FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOSellS15.909,032143,64612,00021 K to 12 K (-42.94 %)
Dec 28 2018FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOBuyM4.882,96814,49121,03218.1 K to 21 K (+16.43 %)
Dec 28 2018FTSVForty Seven, Inc.McCamish Mark AnthonyPresident and CEOBuyM4.889,03244,09918,0649 K to 18.1 K (+100.00 %)
Aug 17 2007PDLIPDL BIOPHARMA, INC ...McCamish Mark AnthonySVP & CMOOption ExerciseA22.1020,000442,00020,000
Feb 23 2007PDLIPDL BIOPHARMA, INC ...McCamish Mark AnthonySVP & CMOOption ExerciseA19.1485,0001,626,90085,000
Feb 23 2007PDLIPDL BIOPHARMA, INC ...McCamish Mark AnthonySVP & CMOGrantA0.007,50007,5000 to 7.5 K

Page:   1

Contact us | Follow us on Twitter